These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 26503156

  • 21. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
    Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL.
    Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
    [Abstract] [Full Text] [Related]

  • 22. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
    Li B, Li N, Cheng G, Sun X, Xu X, Shi J, Li L, Chen C.
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
    [Abstract] [Full Text] [Related]

  • 23. Sebaceoma of the eyelid: a rare entity.
    Mittal R, Tripathy D.
    Can J Ophthalmol; 2014 Jun; 49(3):e78-80. PubMed ID: 24862791
    [No Abstract] [Full Text] [Related]

  • 24. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
    Kiyosaki K, Nakada C, Hijiya N, Tsukamoto Y, Matsuura K, Nakatsuka K, Daa T, Yokoyama S, Imaizumi M, Moriyama M.
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
    [Abstract] [Full Text] [Related]

  • 25. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S, Arase S, Kawana S, Kimura T.
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [Abstract] [Full Text] [Related]

  • 26. Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
    Cho KJ, Khang SK, Koh JS, Chung JH, Lee SS.
    J Korean Med Sci; 2000 Oct; 15(5):545-50. PubMed ID: 11068992
    [Abstract] [Full Text] [Related]

  • 27. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
    Mulay K, Shah SJ, Aggarwal E, White VA, Honavar SG.
    Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
    [Abstract] [Full Text] [Related]

  • 28. Expression of retinoid-X receptors (-alpha,-beta,-gamma) and retinoic acid receptors (-alpha,-beta,-gamma) in normal human skin: an immunohistological evaluation.
    Reichrath J, Mittmann M, Kamradt J, Müller SM.
    Histochem J; 1997 Feb; 29(2):127-33. PubMed ID: 9147069
    [Abstract] [Full Text] [Related]

  • 29. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
    Jayaraj P, Sen S, Sharma A, Chosdol K, Kashyap S, Rai A, Pushker N, Bajaj MS, Ghose S.
    Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
    [Abstract] [Full Text] [Related]

  • 30. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
    Rishi K, Font RL.
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
    [Abstract] [Full Text] [Related]

  • 31. Reduced size of sebaceous gland and altered sebum lipid composition in mice lacking fatty acid binding protein 5 gene.
    Sugawara T, Nemoto K, Adachi Y, Yamano N, Tokuda N, Muto M, Okuyama R, Sakai S, Owada Y.
    Exp Dermatol; 2012 Jul; 21(7):543-6. PubMed ID: 22716252
    [Abstract] [Full Text] [Related]

  • 32. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ, Vollberg TM, Nervi C, Grippo JF, Dawson MI, Jetten AM.
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [Abstract] [Full Text] [Related]

  • 33. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
    Jakobiec FA, Werdich X.
    Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
    [Abstract] [Full Text] [Related]

  • 34. Sebaceous carcinoma of the eyelids: a review of 21 cases.
    Saito A, Tsutsumida A, Furukawa H, Saito N, Yamamoto Y.
    J Plast Reconstr Aesthet Surg; 2008 Nov; 61(11):1328-31. PubMed ID: 17974515
    [Abstract] [Full Text] [Related]

  • 35. Programmed death receptor Ligand 1 expression in eyelid sebaceous carcinoma: a consecutive case series of 41 patients.
    Xu S, Yu H, Fu G, Fan X, Jia R.
    Acta Ophthalmol; 2019 May; 97(3):e390-e396. PubMed ID: 29862664
    [Abstract] [Full Text] [Related]

  • 36. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
    Chen WS, Chen PL, Li J, Lind AC, Lu D.
    J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
    [Abstract] [Full Text] [Related]

  • 37. [Sebaceous carcinoma of the eyelid--two case reports].
    Zieliński T, Antoszewski B.
    Klin Oczna; 2014 Jul; 116(2):127-9. PubMed ID: 25345292
    [Abstract] [Full Text] [Related]

  • 38. Sebaceous carcinoma of the eyelids.
    Karcioglu ZA.
    Ophthalmology; 2005 Sep; 112(9):1641; author reply 1641-2. PubMed ID: 16139675
    [No Abstract] [Full Text] [Related]

  • 39. Foamy gland carcinoma-like carcinoma of the eyelid with sebaceous differentiation.
    Ogawa Y, Kawamura T, Shimada S.
    J Dermatol; 2012 Jun; 39(6):581-3. PubMed ID: 21992411
    [No Abstract] [Full Text] [Related]

  • 40. Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
    Yunoki T, Tabuchi Y, Hayashi A.
    Anticancer Res; 2017 Apr; 37(4):1931-1934. PubMed ID: 28373462
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.